story of the week
Baseline Mutations and ctDNA Dynamics as Prognostic and Predictive Factors in Patients With ER+/HER2− Metastatic Breast Cancer
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Clinical Cancer Research
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Baseline mutations and ctDNA dynamics as prognostic and predictive factors in ER-positive/HER2-negative metastatic breast cancer patients
Clin. Cancer Res 2023 Jul 25;[EPub Ahead of Print], J Pascual, M Gil-Gil, P Proszek, C Zielinski, A Reay, M Ruiz-Borrego, R Cutts, EM Ciruelos Gil, A Feber, M Muñoz-Mateu, C Swift, B Bermejo, J Herranz, M Margeli Vila, A Antón, Z Kahan, T Csöszi, Y Liu, D Fernandez Garcia, I Garcia-Murillas, M Hubank, NC Turner, M MartínFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.